Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice.

Human antibodies and hybridomas Pub Date : 1996-01-01
Y Levy, L Ziporen, B Gilburd, J George, S Polak-Charcon, H Amital, J Cledes, P Youinou, Y Shoenfeld
{"title":"Membranous nephropathy in primary antiphospholipid syndrome: description of a case and induction of renal injury in SCID mice.","authors":"Y Levy,&nbsp;L Ziporen,&nbsp;B Gilburd,&nbsp;J George,&nbsp;S Polak-Charcon,&nbsp;H Amital,&nbsp;J Cledes,&nbsp;P Youinou,&nbsp;Y Shoenfeld","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Primary antiphospholipid syndrome (PAPS) is a recently recognized clinical entity encompassing the combination of thromboembolic phenomena, thrombocytopenia and recurrent abortions in the presence of antiphospholipid antibodies. We present a patient with PAPS accompanied by renal involvement, manifested as membranous nephropathy, as proven by a renal biopsy. To investigate further the possible association between PAPS and the renal lesions we attempted to induce similar renal manifestations by transferring peripheral blood lymphocytes (PBL) from this patient to severe combined immunodeficiency (SCID) mice. The mice transfused with PBL from the affected patient exemplified antiphospholipid antibodies (aPL) following which a renal lesion consistent with the human membranous nephropathy lesion was precipitated. This study substantiates the role of aPL as possible inducers of renal damage.</p>","PeriodicalId":77166,"journal":{"name":"Human antibodies and hybridomas","volume":"7 3","pages":"91-6"},"PeriodicalIF":0.0000,"publicationDate":"1996-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human antibodies and hybridomas","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Primary antiphospholipid syndrome (PAPS) is a recently recognized clinical entity encompassing the combination of thromboembolic phenomena, thrombocytopenia and recurrent abortions in the presence of antiphospholipid antibodies. We present a patient with PAPS accompanied by renal involvement, manifested as membranous nephropathy, as proven by a renal biopsy. To investigate further the possible association between PAPS and the renal lesions we attempted to induce similar renal manifestations by transferring peripheral blood lymphocytes (PBL) from this patient to severe combined immunodeficiency (SCID) mice. The mice transfused with PBL from the affected patient exemplified antiphospholipid antibodies (aPL) following which a renal lesion consistent with the human membranous nephropathy lesion was precipitated. This study substantiates the role of aPL as possible inducers of renal damage.

原发性抗磷脂综合征的膜性肾病:一例SCID小鼠肾损伤的描述和诱导。
原发性抗磷脂综合征(PAPS)是最近公认的一种临床实体,包括血栓栓塞现象、血小板减少症和存在抗磷脂抗体的复发性流产。我们报告了一位伴有肾脏受累的PAPS患者,表现为膜性肾病,经肾活检证实。为了进一步研究PAPS与肾脏病变之间的可能联系,我们试图通过将该患者的外周血淋巴细胞(PBL)转移到严重联合免疫缺陷(SCID)小鼠体内来诱导类似的肾脏表现。输注患者PBL的小鼠出现抗磷脂抗体(aPL),随后出现与人膜性肾病一致的肾脏病变。本研究证实aPL可能是肾损害的诱导剂。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信